« Previous article
Latest Updates on CO...

8th September 2020  Product update: various sources as indicated

Latest Updates on COVID-19 Testing - Kits, Products, Services, Instrumentation


In this week's COVID-19 updates: Clinical studies show CRISPR test as accurate as gold-standard qPCR; Viral Transport Medium (VTM) manufacturer scales up to meet demand; 40 million new CE-marked rapid antigen test made available each month; High-affinity neutralizing antibodies available for research & diagnostics and FDA grant EUA for Influenza and SARS-CoV-2 multiplex assay. 

CRISPR COVID-19 Test - Accurate as Gold-Standard PCR Says Study 

CRISPR COVID-19 Test - Accurate as Gold-Standard PCR Says Study 

Sherlock Biosciences has released outstanding results from a pilot study on its  Sherlock™ CRISPR SARS-CoV-2 kit. The analysis was performed at the Dartmouth-Hitchcock Medical Centre and showed high sensitivity  & specificity across a range of viral loads.
Find Out More

 

Viral Transport Medium Manufacturer Now Does Monthly Output Each Day

Viral Transport Medium Manufacturer Now Does Monthly Output Each Day

Teknova are now manufacturing 30,000 tubes of viral transport medium with the aid of its flexible automated systems. Teknova's VTM and saline is made and validated according to CDC procedures and under GMP conditions.
Find Out More

 

Clinical Diagnostics Firm Make 40 Million CE-Marked Rapid Antigen Tests Available Each Month

Clinical Diagnostics Firm Make 40 Million CE-Marked Rapid Antigen Tests Available Each Month

The SARS-CoV-2 Antigen Test from Roche will be officially launched in late September when they will have 40 million tests available per month, with that number to double by the end of the year. The test shows results in 15 minutes and is CE-marked. 
Find Out More

 

COVID-19 Patient-Derived Neutralizing Antibodies Available 

COVID-19 Patient-Derived Neutralizing Antibodies Available 

The Absolute Antibody catalog now includes neutralizing antibodies for COVID-19 research and diagnostics. The clones are derived from COVID-19 patients and said to bind to the receptor-binding domain and inhibit the virus from binding to ACE2. 
Find Out More

 

FDA Authorizes Flu & SARS-CoV-2 Multiplex Assay 

FDA Authorizes Flu & SARS-CoV-2 Multiplex Assay 

Roche has been granted FDA-EUA for its cobas® SARS-CoV-2 & Influenza A/B Test. The  CE-marked test runs on the cobas 6800/8800 systems which provide up to 96 results in about 3 hours and takes nasal or nasopharyngeal swab samples. 
Find Out More

 

Brazil Approves Finnish SARS-CoV-2 Antibody and Antigen Test Kits 

Brazil Approves Finnish SARS-CoV-2 Antibody and Antigen Test Kits 

Biohit Healthcare's rapid SARS-CoV-2 antigen and antibody tests have been given ANVISA status by the Brazilian Government. The antibody kit is a lateral-flow test, which provides a result in 15 minutes and is already authorized by the US FDA.  
Find Out More

 

Seasonal Flu and Coronavirus Identification

Seasonal Flu and Coronavirus Identification

Influenza and coronavirus are contagious respiratory illnesses. It may be difficult to tell the difference between them because some symptoms are similar and testing may be needed to confirm a diagnosis. 
Find Out More


    

Tags:

Date Published: 8th September 2020

Note: This content has been edited by a rapidmicrobiology staff writer for style and content.


View full company details




rapidmicrobiology.com

Address:

Cork

Ireland

Tel: +[353] 23 88 31884

Email Supplier

View full company details


Related news from rapidmicrobiology.com